ABBV has been in the news 429% more than usual
Mar 18, 2026, 6:31 PM
-0.14%
What does ABBV do
AbbVie is a North Chicago-based biopharmaceutical company that develops and sells medicines across various therapeutic areas, employing 50,000 staff since its IPO in January 2013. Key products include Humira, Botox, and NX-13 for ulcerative colitis.
ABBV has been in the news recently: Protagonist Therapeutics' Icotyde, recently approved by the FDA for moderate-to-severe plaque psoriasis, poses competition to AbbVie’s Skyrizi. Additionally, Johnson & Johnson's new oral psoriasis medication, also named Icotyde, is expected to generate over $5 billion in annual sales, further increasing competition in the psoriasis market.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.